Drug Formulation Development
Early Phase Drug Formulation Development Specialty
Velesco’s preclinical drug development process will ensure exposure in toxicology studies.
Velesco’s expertise in developing pharmaceutical formulations for non-clinical toxicology studies can help optimize exposure. We specialize in small scale, customized experiments that will preserve your limited compound supply. Velesco’s pharmaceutical formulation, be it a binary solution, or a complicated SEDDS (self-emulsifying drug delivery systems) mixture, will be tailored to your molecule, dose range, and drug delivery route. Ideally, we develop an uncomplicated drug formulation that is easy to replicate and can be transferred with ease.
Velesco's preclinical development of drug formulations encompass gels, solutions, and suspensions for oral, IV, or topical dosing.
We can be your partners in your pharmaceutical development, meeting very aggressive timelines by working closely with your toxicologist. Your drug formulation will achieve the concentration requirements without inducing additional adverse toxic effects. Velesco's contract manufacturing pharmaceutical experts have prepared single formulations which are suitable for multiple routes of administration, can be carried forward into later toxicology studies and can even transition into clinical studies.
